Paraquat After Durnell: Will 6,000 Parkinson’s Cases Survive?
Not decided yet — but at serious risk. On June 25, 2026, the Supreme Court held in Monsanto v. Durnell that federal pesticide law preempts state failure-to-warn claims against Roundup, and paraquat lawsuits rest on the same legal theory, so their survival now turns on whether courts extend that reasoning to a different herbicide.
- June 25, 2026: the Supreme Court decided Monsanto v. Durnell by 7–2: FIFRA preempts state failure-to-warn claims about Roundup labels.
- Verdict reversed: the $1.25 million awarded to Missouri plaintiff John Durnell was overturned.
- October 13, 2026: the Court vacated a $28 million Roundup verdict in Dennis v. Monsanto and sent it back under Durnell.
- More than 6,000 federal paraquat claims are pending in MDL 3004 in the Southern District of Illinois.
- Roundup’s count: Bayer says roughly $11 billion paid for nearly 100,000 cases, about 61,000 still pending, plus a proposed $7.25 billion class settlement.
What Durnell Actually Decided
A failure-to-warn claim argues that a manufacturer should have warned users about a risk and did not. FIFRA, the Federal Insecticide, Fungicide, and Rodenticide Act, governs pesticide labels: a maker must register its product with the Environmental Protection Agency (EPA) and sell it only with the EPA-approved label.
In Durnell, a Missouri jury had awarded John Durnell more than $1 million for Monsanto’s alleged failure to warn that glyphosate, Roundup’s active ingredient, could cause cancer. Justice Brett Kavanaugh’s majority held that FIFRA expressly preempts such claims: the EPA has approved Roundup labels since 1974 without a cancer warning and repeatedly found glyphosate not likely to be carcinogenic, so a state jury cannot impose a warning “in addition to or different from” the federal one (7 U.S.C. § 136v(b)). Justice Ketanji Brown Jackson dissented, joined by Justice Neil Gorsuch. The Court decided law, not science: it did not rule that glyphosate is safe or dangerous.
Why Paraquat Cases Rest on the Same Theory
Paraquat is a weed-killing herbicide, and the lawsuits against Syngenta and Chevron claim long-term exposure caused Parkinson’s disease, a progressive movement disorder. Like the Roundup cases, most paraquat claims argue the makers failed to warn applicators, farmworkers, and nearby residents about a risk the EPA-approved label did not carry.
Both sides in the paraquat litigation have told the court that Durnell could determine whether those claims survive, because the legal question is identical in form: can state tort law demand a warning the EPA never required? Plaintiffs will argue their record differs, but that is an argument for a judge, not a settled answer.
The Dennis Warning: What a GVR Does to a Verdict
On October 13, 2026, the Court previewed how Durnell travels. In Dennis v. Monsanto, a California jury had awarded Mike Dennis $332 million, including $325 million in punitive damages, for non-Hodgkin lymphoma allegedly caused by two decades of monthly Roundup use. The trial court cut the award to about $28 million — $7 million compensatory and $21 million punitive — and an appeals court upheld it.
The Supreme Court then issued a GVR, short for grant, vacate, and remand: it granted review, vacated the judgment, and sent the case back for reconsideration under Durnell, without deciding the dispute itself. A GVR is not a final defeat, but it is a loud signal — and a warning that even a verdict surviving trial and appeal can be unwound when the governing standard changes.
The Claims That Could Survive Durnell
Preemption targets claims that would require a different label. Claims that do not depend on the label may survive, and lawyers are now auditing files for them. A design-defect claim says the product was unreasonably dangerous as designed, whatever the label said. A manufacturing-defect claim says a batch departed from its design. An express-warranty claim says the seller broke a specific promise. Negligence theories that do not demand a label change may also survive, depending on how a court frames them.
What will not survive, under Durnell’s logic, is a claim whose only remedy is a warning the EPA did not require. In April 2026, Syngenta announced it would stop producing paraquat, saying the decision was solely for commercial reasons. That changes nothing about past exposure, but it sharpens the question of who remains to pay if liability survives.
Where Paraquat Litigation Stands Now
The federal paraquat cases are consolidated as MDL 3004, with thousands more in state courts. No court has yet definitively applied Durnell to paraquat, and no global paraquat settlement has been announced. Expect briefing and rulings on preemption motions first, then either a narrowed set of surviving claims heading toward test trials or renewed settlement talks under the new legal reality.
Watch three milestones, not headlines: the first MDL 3004 preemption ruling, any appeal from it, and whether settlement talks reopen on Durnell-adjusted terms.
Who Benefits From This — and Who Does Not
Farmworkers, applicators, and landscapers exposed to paraquat who later developed Parkinson’s benefit most: this ruling tells them and their lawyers which theory to lead with and which records to gather now. Ask your lawyer one pointed question: does my case depend on failure to warn, or does it include a design-defect or warranty theory that survives Durnell? For the ruling itself, see our analysis of what the Supreme Court’s FIFRA ruling means for Roundup claims, and for the MDL’s status, our October 2026 paraquat update.
Families of applicators benefit from acting early on evidence: work logs, employer records, product names, and dated diagnosis and treatment records are the spine of any surviving claim.
Three groups gain nothing here. People with no paraquat exposure have no claim to preserve. People seeking a scientific verdict will not find one: Durnell decides which arguments are available, not whether any herbicide causes disease. And anyone hoping for a typical payout figure will be disappointed honestly: none exists.
Frequently Asked Questions
Who benefits most from understanding the Durnell ruling?
Paraquat applicators and farmworkers diagnosed with Parkinson’s benefit most, because the ruling changes which legal theories their claims can use.
Who does Durnell not help, and who is not eligible to bring a paraquat claim?
It does not help people with no paraquat exposure; a claim still requires exposure plus a diagnosis supported by medical records.
How do I benefit, and how do I start?
List every product you sprayed or worked around, with dates and employers, gather your diagnosis and treatment records, then ask a lawyer which theory your claim rests on and whether it survives Durnell.
Does Durnell mean paraquat cases are over?
No. Durnell decided a Roundup case, not a paraquat case. Paraquat claims face a serious new obstacle, but no court has ruled that Durnell ends them, and non-label theories may still proceed.
What happened to the $28 million Dennis verdict?
On October 13, 2026, the Supreme Court vacated the $28 million judgment in Dennis v. Monsanto and sent it back for reconsideration under Durnell. A vacated verdict is not a final loss, but it must now survive a stricter standard.
Does the ruling say Roundup or paraquat is safe?
No. The Court ruled on preemption — whether state law can require a warning the EPA did not — not on whether either herbicide causes disease.
This article is general information, not legal advice. Deadlines and eligibility vary by state and court; consult a licensed attorney about your own situation. For more plain-English explainers on cases like this, visit the Problem Solved channel.